Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1423-2025Class II

Baxter NovumIQ Syringe INFUSION SYSTEM , REF 40800BAXUS

Baxter Healthcare Corporation / initiated 2025-03-03 / Open, Classified / root cause: manufacturing process

Baxter Healthcare Corporation began a recall of Baxter NovumIQ Syringe INFUSION SYSTEM , REF 40800BAXUS on . FDA classified it as Class II and gives the reason as "Baxter Healthcare Corporation is issuing an Urgent Medical Device Recall for the Novum IQ syringe pumps listed below due to an incorrectly installed gasket. A gasket failure could lead to potential fluid ingress due to...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1423-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Baxter Healthcare Corporation
Product
Baxter NovumIQ Syringe INFUSION SYSTEM , REF 40800BAXUS
Product code
FRN Pump, Infusion
Reason for recall
Baxter Healthcare Corporation is issuing an Urgent Medical Device Recall for the Novum IQ syringe pumps listed below due to an incorrectly installed gasket. A gasket failure could lead to potential fluid ingress due to cleaning, or as a result of an IV fluid spill.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
Baxter issued an URGENT MEDICAL DEVICE RECALL notice to its consignees on 03/03/2025 via USPS first class mail. The notice explained the issue, hazard involved and requested the following: Actions to be Taken by Customers 1. Immediately locate, isolate, and cease all use of Novum IQ Syringe pumps with the affected serial numbers. The product code and serial number can be found on the bottom of the syringe pump. 2. Contact Baxter to arrange for the return of the affected pumps for repair. Baxter Global Technical Services can be reached at 800-843-7867 (press option 2, then option 2) Monday through Friday, between 7:00 am and 7:00 pm Eastern Time. 3. Acknowledge receipt of this notification by following the instructions on the enclosed reply instruction sheet, even if you have no remaining inventory. Acknowledging receipt will prevent you from receiving repeat notices. If you do not complete the acknowledgement, you will receive a phone call from OnProcess Technology on behalf of Baxter to confirm your receipt of this notification. 4. Please forward a copy of this communication to the Chief Medical Officer, Medical Director, Director of Nursing, Director of Pharmacy, Facility Risk Manager, Director of Purchasing/Central Supply, and any other departments within your institution who use the affected product. For general questions regarding this communication, or if you experience quality problems, please contact your Baxter sales representative, or Baxter Global Technical Services at 800-843-7867 Monday through Friday, between 7:00 am and 7:00 pm Eastern Time.
Quantity in commerce
149 units
Distribution
US Nationwide distribution in the states of AR, CA, FL, IA, IN, LA, MO, MT, NC, NY, OH, OR, PA, TN, TX, VA, WA, WI, WV.
Product codes and lots
UDI/DI 05413765852428, Serial Numbers: 02A220600103, 02A221100387, 02A240800201, 02A230300471, 02A240800161, 02A220600112, 02A230100474, 02A240800343, 02A230400357, 02A240800175, 02A220700259, 02A230200471, 02A240800710, 02A230600165, 02A240800223, 02A220700176, 02A230200487, 02A240900081, 02A230600175, 02A240800513, 02A220700349, 02A230300030, 02A240900133, 02A230600176, 02A240800577, 02A220700268, 02A230300117, 02A240900265, 02A230600255, 02A240900261, 02A220700081, 02A230300125, 02A240900277, 02A230600256, 02A240900421, 02A220700140, 02A230300132, 02A240900285, 02A230600618, 02A240900742, 02A220700351, 02A230300146, 02A240900287, 02A230700137, 02A240900746, 02A220700409, 02A230300275, 02A240900282, 02A241000576, 02A240901067, 02A220700368, 02A230300287, 02A240900373, 02A220700166, 02A240901181, 02A220700428, 02A230300309, 02A240900407, 02A221000108, 02A240901422, 02A220700450, 02A230300350, 02A240900422, 02A221000346, 02A240901428, 02A220700454, 02A230300389, 02A240900423, 02A221000349, 02A240901430, 02A220700458, 02A230300477, 02A240900443, 02A221100154, 02A241000027, 02A220800010, 02A230300520, 02A240900427, 02A221100208, 02A241000051, 02A220800060, 02A230300547, 02A240900502, 02A221100201, 02A241000251, 02A220800201, 02A230400035, 02A240900681, 02A230200462, 02A241000254, 02A220800407, 02A230400145, 02A240900677, 02A230200495, 02A241000366, 02A221000109, 02A230600421, 02A240900749, 02A230300091, 02A241000479, 02A221000233, 02A230600549, 02A240900811, 02A230300342, 02A241000862, 02A221000240, 02A230600792, 02A240900981, 02A230300367, 02A241001284, 02A221000360, 02A230600820, 02A240901095, 02A230300417, 02A241001392, 02A221000099, 02A230600894, 02A240901196, 02A230300533, 02A241001413, 02A221100056, 02A230600908, 02A240901243, 02A230400030, 02A241001478, 02A221100116, 02A230700053, 02A241000498, 02A230600496, 02A241001496, 02A221100244, 02A230700043, 02A241000939, 02A240800026, 02A241100021, 02A221100260, 02A240600468, 02A241000957, 02A240800050, 02A241100037, 02A221100294, 02A240800006, 02A230300466, 02A240800069, 02A241100047, 02A221100346, 02A240800007, 02A230300467, 02A240800142.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1423-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1423-2025Class IIOngoingVoluntary: Firm initiated